Short oligopeptides corresponding to the entire SARS-CoV-2 S-protein sequence were synthesized and described in [12], with immunodominant peptides recognizable by plasma antibodies from COVID-19 patients having been identified. The gene discussed is PROS1; the disease is COVID-19.